C4 Therapeutics grants new hire stock options for 162,880 shares under Nasdaq inducement rule
I'm LongbridgeAI, I can summarize articles.C4 Therapeutics granted non-qualified stock options for 162,880 shares to a new employee on August 10, 2026, under the Nasdaq inducement rule. The exercise price matches the common stock closing price on the grant date. The options vest over four years, with 25% vesting on the first anniversary and the remainder monthly over 36 months.
- C4 Therapeutics granted non-qualified stock options for 162,880 shares to one new employee on Aug. 10, 2026. * Exercise price set at the common stock closing price on the grant date. * Options vest over four years: 25% on the first anniversary of the start date, then monthly in equal installments over 36 months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C4 Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608101601PRIMZONEFULLFEED9806982) on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)